Extended High‐Risk HPV Genotyping With BD Onclarity Enhances Anal Cancer Screening Among High‐Risk Populations: A Cross‐Sectional Study
Daisy Maharjan, Joshua Waters, Melissa Randolph, Benjamin Shuler, Julie Borum, Sheila Segura · 2026
Read Extended High‐Risk HPV Genotyping With BD Onclarity Enhances Anal Cancer Screening Among High‐Risk Populations: A Cross‐Sectional Study by Daisy Maharjan, Joshua Waters, Melissa Randolph, Benjamin Shuler, Julie Borum, Sheila Segura (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13532612.txt.
Description
Daisy Maharjan and colleagues study in 2026 anal cancer screening with a test that names high-risk HPV types in detail. Anal cancer is rising in women, people with weak immune systems, and men who have sex with men. The single-centre study enrolled 117 high-risk people from May 2024 to May 2025.
Cell tests were abnormal in 41 percent of cases, and valid HPV results came from 104 people. Most positive results were types other than 16 and 18, while type 16 linked more with abnormal cells. Twelve people had biopsies, so the authors treat the links as early clues, not proof.
Catalog record
| CREATOR | Daisy Maharjan, Joshua Waters, Melissa Randolph, Benjamin Shuler, Julie Borum, Sheila Segura |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26867 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |